149 related articles for article (PubMed ID: 24901561)
21. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
23. Development of animal models for adeno-associated virus site-specific integration.
Rizzuto G; Gorgoni B; Cappelletti M; Lazzaro D; Gloaguen I; Poli V; Sgura A; Cimini D; Ciliberto G; Cortese R; Fattori E; La Monica N
J Virol; 1999 Mar; 73(3):2517-26. PubMed ID: 9971837
[TBL] [Abstract][Full Text] [Related]
24. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome.
Hüser D; Gogol-Döring A; Lutter T; Weger S; Winter K; Hammer EM; Cathomen T; Reinert K; Heilbronn R
PLoS Pathog; 2010 Jul; 6(7):e1000985. PubMed ID: 20628575
[TBL] [Abstract][Full Text] [Related]
25. AAV vectors for the nucleolus.
Russell DW
Mol Ther; 2012 Oct; 20(10):1842-3. PubMed ID: 23023058
[No Abstract] [Full Text] [Related]
26. Topics in AAV integration come front and center at ASGCT AAV Integration Roundtable.
Sabatino DE; McCarty DM
Mol Ther; 2021 Dec; 29(12):3319-3320. PubMed ID: 34758291
[No Abstract] [Full Text] [Related]
27. AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.
Mingozzi F; Meulenberg JJ; Hui DJ; Basner-Tschakarjan E; Hasbrouck NC; Edmonson SA; Hutnick NA; Betts MR; Kastelein JJ; Stroes ES; High KA
Blood; 2009 Sep; 114(10):2077-86. PubMed ID: 19506302
[TBL] [Abstract][Full Text] [Related]
28. Targeted integration of a rAAV vector into the AAVS1 region.
Ward P; Walsh CE
Virology; 2012 Nov; 433(2):356-66. PubMed ID: 22981435
[TBL] [Abstract][Full Text] [Related]
29. Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration.
Guilbaud M; Chadeuf G; Avolio F; François A; Moullier P; Recchia A; Salvetti A
J Virol; 2008 Mar; 82(5):2590-3. PubMed ID: 18094174
[TBL] [Abstract][Full Text] [Related]
30. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.
Kearns WG; Afione SA; Fulmer SB; Pang MC; Erikson D; Egan M; Landrum MJ; Flotte TR; Cutting GR
Gene Ther; 1996 Sep; 3(9):748-55. PubMed ID: 8875221
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration.
Wang Y; Camp SM; Niwano M; Shen X; Bakowska JC; Breakefield XO; Allen PD
J Virol; 2002 Jul; 76(14):7150-62. PubMed ID: 12072515
[TBL] [Abstract][Full Text] [Related]
32. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus vectors.
Carter BJ
Curr Opin Biotechnol; 1992 Oct; 3(5):533-9. PubMed ID: 1369403
[TBL] [Abstract][Full Text] [Related]
34. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro.
Yang CC; Xiao X; Zhu X; Ansardi DC; Epstein ND; Frey MR; Matera AG; Samulski RJ
J Virol; 1997 Dec; 71(12):9231-47. PubMed ID: 9371582
[TBL] [Abstract][Full Text] [Related]
35. Sites of recombinant adeno-associated virus integration.
Rivadeneira ED; Popescu NC; Zimonjic DB; Cheng GS; Nelson PJ; Ross MD; DiPaolo JA; Klotman ME
Int J Oncol; 1998 Apr; 12(4):805-10. PubMed ID: 9499439
[TBL] [Abstract][Full Text] [Related]
36. Adeno-associated virus-mediated gene transfer in hematopoietic stem/ progenitor cells as a therapeutic tool.
Zhong L; Zhao W; Wu J; Maina N; Han Z; Srivastava A
Curr Gene Ther; 2006 Dec; 6(6):683-98. PubMed ID: 17168699
[TBL] [Abstract][Full Text] [Related]
37. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells.
Ponnazhagan S; Erikson D; Kearns WG; Zhou SZ; Nahreini P; Wang XS; Srivastava A
Hum Gene Ther; 1997 Feb; 8(3):275-84. PubMed ID: 9048194
[TBL] [Abstract][Full Text] [Related]
38. Characterization of adeno-associated virus genomes isolated from human tissues.
Schnepp BC; Jensen RL; Chen CL; Johnson PR; Clark KR
J Virol; 2005 Dec; 79(23):14793-803. PubMed ID: 16282479
[TBL] [Abstract][Full Text] [Related]
39. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome.
Giraud C; Winocour E; Berns KI
J Virol; 1995 Nov; 69(11):6917-24. PubMed ID: 7474109
[TBL] [Abstract][Full Text] [Related]
40. Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells.
Tsunoda H; Hayakawa T; Sakuragawa N; Koyama H
Virology; 2000 Mar; 268(2):391-401. PubMed ID: 10704347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
